# Assessment of Serum Cytokine Levels in Keratoconus Patients

**Authors:** Noor Alqudah, Nosayba Al-Azzam, Leen El Taani, Abdallah Sharayah, Mohammad Al Qudah, Khawlah Mhedat, Suha Tahat

PMC · DOI: 10.3390/jcm14093179 · Journal of Clinical Medicine · 2025-05-04

## TL;DR

This study found no significant differences in serum inflammation markers between keratoconus patients and healthy individuals, suggesting the condition may involve local rather than systemic inflammation.

## Contribution

The study provides new evidence that systemic inflammation does not play a significant role in keratoconus.

## Key findings

- Serum levels of IL-6, TNF-α, and IL-1β were not significantly different between keratoconus patients and healthy controls.
- No significant correlations were found between cytokine levels and keratoconus severity.
- The findings support the idea that keratoconus is primarily associated with local rather than systemic inflammation.

## Abstract

Background: While keratoconus (KC) has traditionally been classified as a non-inflammatory corneal disorder, emerging evidence suggests that inflammatory processes may be involved in its pathogenesis. This study investigated whether systemic inflammation contributes to KC development by measuring serum levels of key pro-inflammatory cytokines in KC patients compared to healthy controls. Methods: This cross-sectional comparative study included 60 participants aged 18–30 and was divided into three equal groups: healthy controls, progressive KC, and stable KC. The levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interleukin-1 beta (IL-1β) in the serum were measured through an enzyme-linked immunosorbent assay. KC severity was classified based on mean keratometry values. Results: There were no significant differences detected in serum IL-6, TNF-α, and IL-1β levels across groups (p > 0.05). Moreover, no significant correlations were found between systemic cytokine levels and KC severity categories (p > 0.05). Conclusions: Systemic levels of IL-1β, IL-6, and TNF-α do not significantly differ between KC patients and controls nor do they correlate with disease severity, reinforcing the hypothesis that KC involves primarily local inflammatory processes.

## Linked entities

- **Proteins:** IL6 (interleukin 6)
- **Diseases:** keratoconus (MONDO:0015486)

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}
- **Diseases:** corneal disorder (MESH:D003316), KC (MESH:D007640), inflammation (MESH:D007249)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12072575/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12072575/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12072575/full.md

---
Source: https://tomesphere.com/paper/PMC12072575